The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Phase 1 · 665 people · 17 sites in 2 countries · Recruiting now

August 11, 2026
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Phase 1 · 404 people · 22 sites in 5 countries · Recruiting now

August 11, 2026
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Phase 2 · randomised · 97 people · 2 sites in United States · Recruiting now

August 11, 2026
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Phase 2 · 126 people · 5 sites in United States · Recruiting now

August 11, 2026
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Phase 2 · 40 people · 1 site in United States · Recruiting now

August 11, 2026
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Phase 2 · 50 people · 9 sites in United States · Recruiting now

August 11, 2026
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Phase 1 · randomised · 27 people · 1 site in United States · Recruiting now

August 11, 2026
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

Phase 1 · 39 people · 8 sites in United States · Recruiting now

August 11, 2026
YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Phase 1 · 9 people · 1 site in China · Recruiting now

August 11, 2026
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Phase 1 · 108 people · 18 sites in United States · Recruiting now

August 11, 2026